Rheumatology Doctors in Katy, TX Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Dr. Kiran Farheen, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 23920 Katy Fwy Ste 240, Katy, TX 77494 Phone: 346-257-4299    Fax: 877-764-7610

Dr. Maryam Khawari, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 777 S Fry Rd Ste 102, Katy, TX 77450 Phone: 281-652-5943    Fax: 281-652-5944

Dr. Seema Malani, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2630 N Mason Rd Ste A2, Katy, TX 77449 Phone: 281-712-8360    Fax: 281-712-8361

Tara Rizvi, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 23920 Katy Fwy Ste 440, Katy, TX 77494 Phone: 346-257-4300    Fax: 346-202-0088

Dr. Padma Rao Chimata, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 402 Park Grove Drive, Katy, TX 77450 Phone: 281-578-7438

News Archive

Novel AI voice tool can help diagnose PTSD

A specially designed computer program can help diagnose post-traumatic stress disorder (PTSD) in veterans by analyzing their voices, a new study finds.

PAS 2021 Virtual Meeting to discuss intersectionality of child poverty

A state of the art plenary session during the Pediatric Academic Societies (PAS) 2021 Virtual Meeting will bring together national experts on child poverty, racism and racial inequities, immigrant health, Native American culture, and environmental threats to discuss the intersectionality of child poverty.

Asian poison ivy like plant may stop prostate cancer

The croton plant, long known to oriental herbalists and homeopaths as a purgative, has an oil in its seeds that shows promise for the treatment of prostate cancer – the second leading cause of cancer death in men in the United States. The active ingredient in the oil is 12-O-tetradecanoylphorbol-13-acetate, a compound generally known as TPA.

Adimab announces the completion of Series D financing

Adimab, Inc., a world leader in human antibody discovery, today announced the closing of a Series D financing led by Google Ventures with participation by previous investors Polaris Ventures, SV Life Sciences, OrbiMed Advisors and Borealis Ventures. Bill Maris of Google Ventures will join Adimab's Board of Directors. The total amount of the financing was not disclosed.

Study estimates global trends in diabetes prevalence

A female researcher from UPM is involved in a study that estimates the global prevalence of diabetes and anticipates future trends.

Read more Medical News

› Verified 8 days ago